Advertisement

Search Results

Advertisement



Your search for Narjust Duma, MD, and Gilberto Lopes, MD, MBA, FAMS, FASCO matches 1 pages

Showing 1 - 1


lung cancer

Erlotinib Plus Ramucirumab: Ready for Prime Time?

The treatment of epidermal growth factor receptor (EGFR)-positive lung cancer changed dramatically after the results of the FLAURA trial showed improved progression-free survival with the third-generation EGFR tyrosine kinase inhibitor osimertinib as first-line therapy compared with...

Advertisement

Advertisement



Advertisement